Skip to main content
Fig. 1 | Diagnostic Pathology

Fig. 1

From: miR-132 serves as a diagnostic biomarker in gestational diabetes mellitus and its regulatory effect on trophoblast cell viability

Fig. 1

Expression of miR-132 and its correlation with fasting blood glucose in patients with GDM. a and b. Expression of miR-132 in serum (a) and placenta tissue (b) was downregulated in GDM patients compared with the healthy women. c. Serum miR-132 levels were negatively correlated with the fasting blood glucose of the GDM patients (r = − 0.490, P < 0.001). ***P < 0.001

Back to article page

Diagnostic Pathology

ISSN: 1746-1596

Contact us